Radiopharmaceuticals

What experts have said about Radiopharmaceuticals

1 statement · 1 positive

1. Oleg NodelmanPositiveJun 12, 2026· All-In with Chamath, Jason, Sacks & Friedberg

   Radiopharmaceuticals have a competitive moat because China cannot access radioisotopes

   “because the class involves radioisotopes, it's off limits to China”

   Listen at 33:33

   Open the episode · All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.